There are certain risk factors for COPD, including obesity and having type 2 diabetes. A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications ...

It’s a brand-name prescription drug used to treat chronic obstructive pulmonary disease (COPD) and asthma in adults. Trelegy Ellipta comes as a powder you inhale into your lungs using the ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW medical editor Dr. Brian McDonough has more.

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

A new study suggests COPD patients experience improved lung ... as both can be fearful of losing control of the disease in a change of medication. The CRYSTAL trial is the first large-scale ...

A recent study conducted by researchers from Seattle-based University of Washington and Durham, N.C.-based Duke University found a strong association between the use of fall-risk increasing drugs ...

People with COPD experience more falls and related ... Opioids, benzodiazepines and other medications used to treat these comorbidities and symptoms can increase a person's risk of falling and ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...